Immunology and Microbiology
Upregulation
100%
Cell Cycle
100%
Parasitology
100%
Leishmania infantum
100%
Cytotoxicity
50%
Cell Membrane
50%
IC50
50%
Mitochondrion
50%
Leishmania
50%
Amastigote
50%
Fluorescence Spectroscopy
50%
Electric Potential
50%
Visceral Leishmaniasis
50%
Mitochondrial Membrane Potential
50%
Incubation Time
50%
CC50
50%
Cytotoxic Concentration
50%
Keyphrases
Leishmania Infantum
100%
Antidepressants
100%
Escitalopram
100%
Antileishmanial Potential
100%
Dose Effect
28%
Neglected Tropical Diseases
28%
Electric Potential
14%
Life Cycle Analysis
14%
Efficacy Study
14%
IC50 Value
14%
Incubation
14%
Depolarization
14%
Amastigote
14%
Flow Cytometry
14%
Reactive Oxygen Species
14%
Mitochondrial Membrane Potential
14%
Molecular Alterations
14%
Fluorescent Probe
14%
Approved Drugs
14%
Visceral Leishmaniasis
14%
Antileishmanial Activity
14%
ATP Level
14%
MTT Assay
14%
Cellular Alterations
14%
Cost-effective Approach
14%
Plasma Membrane Permeability
14%
Mammalian Cytotoxicity
14%
Calcium Level
14%
Drug Repositioning
14%
Cytotoxic Concentration
14%
SYTOX Green
14%
CC50
14%
Bioluminescent Assay
14%
Spectrofluorimetry
14%
Animal Efficacy
14%
Fragmented DNA
14%
Single Mitochondrion
14%
Medicine and Dentistry
Leishmania infantum
100%
Escitalopram
100%
Antidepressant
100%
Upregulation
28%
Reactive Oxygen Species
28%
Neglected Tropical Diseases
28%
Parasitology
28%
Efficacy Study
14%
Cell Cycle
14%
Adenosine Triphosphate
14%
Cell Membrane
14%
Mitochondrion
14%
Health Care Cost
14%
IC50
14%
Isotopes of Calcium
14%
Ex Vivo
14%
Mitochondrial Membrane Potential
14%
Cytotoxicity
14%
Spectrofluorometry
14%
Incubation Time
14%
Leishmania
14%
Flow Cytometry
14%
MTT Assay
14%
Visceral Leishmaniasis
14%
Cell-Cycle Analysis
14%
Drug Repositioning
14%
Fluorescent Dye
14%
Pharmacology, Toxicology and Pharmaceutical Science
Antidepressant
100%
Escitalopram
100%
Leishmania infantum
100%
Tropical Disease
28%
IC50
14%
Adenosine Triphosphate
14%
Leishmania
14%
Amastigote
14%
Fluorescent Dye
14%
Flow Cytometry
14%
Incubation Time
14%
Visceral Leishmaniasis
14%
Efficacy Study
14%
Drug Repositioning
14%
Cytotoxicity
14%